Piramal targets becoming the global market leader in development & manufacturing of Antibody Drug Conjugates (ADCs)

    © 2024 Piramal Enterprises Ltd.

    Piramal encourages pharma to embrace green chemistry ahead of CPhI

    Piramal Enterprises considers potential acquisition of Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

    Piramal Enterprises’ Pharma Solution division receives four CMO Leadership Awards 2015

    Piramal Enterprises’ Pharma Solution Division receives two coveted CMO Leadership Awards (2013) for “Quality ” and “Reliability “

    Five Star Safety Ratings awarded to Piramal Enterprises Ltd. by British Safety Council

    Piramal | Healthcare to invest $ 11 million in hormonal healthcare production at its Morpeth, UK, facility

    Piramal’s healthcare vertical invests USD $2.5 million to further expand commercial ADC capacity